Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19-Reference-Cited by-同舟云学术

Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19

Published:2020-12 Issue: Volume:196 Page:222-226
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Zermatten Maxime G.,Pantet Olivier,Gomez Francisco,Schneider Antoine,Méan Marie,Mazzolai Lucia,Hugli Olivier^ORCID,Bart Pierre-Alexandre,Papadimitriou-Olivgeris Matthaios,Alberio Lorenzo^ORCID

Publisher

Elsevier BV

Subject

Hematology

Reference10 articles.

1. Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study;Wichmann;Ann. Intern. Med.,2020

2. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study;Helms;Intensive Care Med.,2020

3. Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients;Schulman;J. Thromb. Haemost.,2005

4. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia;Cui;J. Thromb. Haemost.,2020

5. VTE incidence and risk factors in patients with severe sepsis and septic shock;Kaplan;Chest,2015

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of three thromboprophylaxis regimens in critically ill COVID-19 patients: An analysis of real-world data;Frontiers in Cardiovascular Medicine;2022-08-16

2. Acute Venous Disease Anomalies in Critically Ill COVID-19 Patients;Cureus;2022-07-20

3. COVID and venous thrombosis: systematic review of literature;The Journal of Cardiovascular Surgery;2022-01

4. Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19;JAMA Network Open;2021-11-22

5. Prévention du risque thromboembolique veineux et surveillance de l’hémostase chez les patients hospitalisés pour COVID-19 : propositions réactualisées (avril 2021). Groupe d’intérêt en hémostase périopératoire (GIHP) et groupe d’étude sur l’hémostase et la thrombose (GFHT);Anesthésie & Réanimation;2021-11